H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys

Invest Ophthalmol Vis Sci. 1999 Jan;40(1):239-42.

Abstract

Purpose: To determine the effects of the serine-threonine kinase inhibitor H-7 on total outflow facility in iridectomized + ciliary muscle (CM)- disinserted, and on trabecular facility in normal, monkey eyes.

Methods: Total outflow facility was determined by two-level constant pressure perfusion of the anterior chamber. Trabecular outflow facility was determined from accumulation in blood of intracamerally infused radioiodinated albumin at two intraocular pressure levels.

Results: Three-hundred micromoles of intracameral H-7 doubled facility in iridectomized + CM- disinserted monkey eyes and contralateral iridectomized-only eyes. Four 5-microl drops of 400 mM H-7 applied topically followed 2 hours later by anterior chamber exchange for 10 minutes and intracameral infusion for 90 minutes with 100 microM H-7 increased trabecular and total outflow facility by 135%+/-29% and 105%+/-35% (n 5, P < 0.01, P < 0.05), respectively, compared with contralateral vehicle-treated eyes.

Conclusions: H-7 increases trabecular outflow facility in monkeys by a mechanism independent of the CM, presumably acting directly on the trabecular meshwork.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / administration & dosage
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology*
  • Animals
  • Anterior Chamber
  • Aqueous Humor / metabolism*
  • Blood-Aqueous Barrier / physiology
  • Ciliary Body / physiology
  • Ciliary Body / surgery*
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology*
  • Iris / surgery
  • Macaca fascicularis
  • Macaca mulatta
  • Muscle, Smooth / physiology
  • Muscle, Smooth / surgery*
  • Ophthalmic Solutions
  • Perfusion
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Trabecular Meshwork / drug effects*
  • Trabecular Meshwork / physiology

Substances

  • Enzyme Inhibitors
  • Ophthalmic Solutions
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Protein Serine-Threonine Kinases